Skip to main content
OpenTrials

Clinical trial condition

Dyskinesias

Explore clinical trials studying Dyskinesias. Study availability and eligibility vary by location and protocol.

123 public trials 15 recruiting studies
Refine in advanced search Browse all conditions

Dyskinesias trial results

Completed

Study to Assess the Safety, Tolerability and Preliminary Efficacy of NLX-112 Versus Placebo in L-dopa-induced Dyskinesia

NCT05148884

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +16 more
Locations
  • Sahlgrenska Hospital Gothenburg, Sweden
  • Skåne University Hospital Lund, Sweden
  • ASC Torsplan Stockholm, Sweden
  • Karolinska University Hospital, Solna Stockholm, Sweden
View Trial Details
Completed

Hip Activation and FSDT

NCT05642065

Conditions
Central Nervous System Diseases, Dyskinesias, Lower Extremity Problem, +6 more
Locations
  • Louisiana State University Health Sciences Center - Shreveport Shreveport, Louisiana, United States
View Trial Details
Completed

Validation of Dyskinesia Rating Scales

NCT01071395

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +11 more
Locations
  • University of Alabama-Birmingham (UAB) Birmingham, Alabama, United States
  • University of South Florida Tampa, Florida, United States
  • Rush University Medical Center Chicago, Illinois, United States
  • Duke University Durham, North Carolina, United States
View Trial Details
Completed

Open Label Continuation Treatment Study With Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease

NCT00660673

Conditions
Advanced Parkinson's Disease, Basal Ganglia Diseases, Brain Diseases, +11 more
Locations
  • University of Alabama at Birmingham /ID# 49941 Birmingham, Alabama, United States
  • The Research Center of Southern California /ID# 49928 Encinitas, California, United States
  • The Parkinson's & Movement Disorder Institute - Fountain Valley /ID# 49915 Fountain Valley, California, United States
  • Universtiy of Southern California /ID# 49913 Los Angeles, California, United States
View all 61 locations
View Trial Details
Completed

Reducing Involuntary Movements in Participants With Tardive Dyskinesia

NCT02198794

Conditions
Central Nervous System Diseases, Dyskinesia, Drug-Induced, Dyskinesias, +6 more
Locations
  • Teva Investigational Site 145 Tuscaloosa, Alabama, United States
  • Teva Investigational Site 107 Anaheim, California, United States
  • Teva Investigational Site 108 Anaheim, California, United States
  • Teva Investigational Site 123 Glendale, California, United States
View all 82 locations
View Trial Details

Related conditions